Lataa...
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
Isocitrate dehydrogenases (IDHs) are enzymes that catalyze the oxidative decarboxylation of isocitrate, producing α-ketoglutarate (αKG) and CO(2). The discovery of IDH1 and IDH2 mutations in several malignancies has brought to the approval of drugs targeting IDH1/2 mutants in cancers. Here, we summa...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6520797/ https://ncbi.nlm.nih.gov/pubmed/31010244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040563 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|